{
 "episode_id": "the-diary-of-a-ceo-2026-07-16-leading-cancer-researcher-they-re-ignoring-my-research-cance",
 "title": "Leading Cancer Researcher: They're Ignoring My Research, Cancer Patients Must Know This!",
 "podcast": "the-diary-of-a-ceo",
 "published_at": "2026-07-16",
 "speakers": [
  "Steven Bartlett",
  "Thomas Seyfried"
 ],
 "summary": "Thomas Seyfried, a cancer biologist at Boston College, argues across this conversation that cancer is not fundamentally a genetic disease but a mitochondrial metabolic disorder: chronic damage to the mitochondria (from carcinogens, forever chemicals, inflammation, poor diet, inactivity, and stress) forces cells back onto ancient oxygen-independent fermentation pathways, driving the dysregulated growth we call cancer. He explains that tumor cells are fueled by glucose and glutamine and cannot burn ketones because their mitochondria are structurally corrupted, which is the basis of his Glucose Ketone Index (GKI) — a biomarker of mitochondrial health — and his 'Press-Pulse' metabolic therapy that puts patients into nutritional ketosis so standard chemo, radiation, and immunotherapy work at far lower doses. Seyfried is openly angry that mainstream oncology, wedded to the somatic mutation theory, ignores this science while roughly 1,700 Americans die of cancer each day, and he points to long-term survivors of inoperable glioblastoma (Pablo Kelly, Trudy DuPont) managed with metabolic therapy. Steven Bartlett interleaves researched statistics (2026 American Cancer Society projections, IARC's carcinogen classifications, Valter Longo's fasting research) and walks through prevention policy in a 'if you were president' framing that lands on patient education, healthy-food access, exercise, and stress reduction. The episode closes on Seyfried's insistence that this is patient-empowering knowledge, not a cure, and that the cancer system will only change as more successful case reports accumulate.",
 "topics": [
  {
   "name": "The embargoed paper and Seyfried's anger at cancer deaths",
   "timestamp": "1:04",
   "summary": "Seyfried reveals a confidential, embargoed paper he says will be a lead article in Frontiers in Science, laying out a strategy to manage cancer effectively, and voices anger that ~1,700 Americans die of cancer daily while the field ignores the mitochondrial origin of the disease."
  },
  {
   "name": "Mitochondria 101 — the organelle, ATP, and oxidative phosphorylation",
   "timestamp": "4:04",
   "summary": "Seyfried defines cancer as a mitochondrial metabolic disease originating in the mitochondrion, explains how the organelle uses oxygen to make ATP efficiently, and how carcinogens, ROS, and intermittent hypoxia damage its delicate membranes."
  },
  {
   "name": "The oncogenic paradox, the Warburg effect, and fermentation",
   "timestamp": "15:40",
   "summary": "Seyfried presents the oncogenic paradox — many different agents cause cancer with no shared mechanism — and resolves it via damaged mitochondria falling back on ancient fermentation, citing Otto Warburg's observation that cancer cells ferment even in full oxygen."
  },
  {
   "name": "Two fuels: glucose and glutamine drive dysregulated growth",
   "timestamp": "24:38",
   "summary": "Cancer cells are described as inefficient, greedy fermenters dependent on glucose and the amino acid glutamine, unable to burn fatty acids or ketones because the mitochondria are broken."
  },
  {
   "name": "Causes: exposures over choices, and why children get cancer",
   "timestamp": "29:04",
   "summary": "Seyfried stresses cancer often results from environmental exposure (carcinogens, forever chemicals crossing the placenta, inflammation, hypoxia) rather than lifestyle choices alone, explaining brain cancer in infants."
  },
  {
   "name": "Global cancer geography — paleolithic vs modern, dog vs wolf",
   "timestamp": "30:05",
   "summary": "Discussion of why high-income countries have the highest cancer rates while traditional-living populations have low rates, using the domestic dog vs wild wolf and Albert Schweitzer's African observations; genetic mutations are noted to be incompletely penetrant."
  },
  {
   "name": "Ketones, fat, and the Glucose Ketone Index",
   "timestamp": "38:38",
   "summary": "Seyfried introduces the GKI as the first biomarker of mitochondrial health, explains ketones as a breakdown product of stored fat that can replace glucose, and tells the origin story of the index via cancer patient Trudy DuPont."
  },
  {
   "name": "The GKI zones chart and Steven's live reading",
   "timestamp": "50:30",
   "summary": "The green/yellow/red zone chart is explained as prevention vs risk; Steven pricks his finger and computes a GKI of 12.5, landing in the prevention zone, and Seyfried recounts reaching ~1 on a carnivore diet."
  },
  {
   "name": "Metabolic therapy: ketosis + low-dose chemo, and targeting glutamine",
   "timestamp": "58:42",
   "summary": "Seyfried explains that nutritional ketosis makes tumor cells vulnerable so chemo, radiation, and immunotherapy work at much lower doses, and that glutamine must be separately targeted with repurposed drugs like mebendazole; cites glioblastoma survivor Pablo Kelly."
  },
  {
   "name": "Cachexia and why oncologists fear keto",
   "timestamp": "1:04:27",
   "summary": "Steven raises oncologists' fear that keto worsens cachexia; Seyfried reframes cachexia as the tumor mobilizing glutamine from muscle, and ketogenic weight loss as therapeutic rather than pathological."
  },
  {
   "name": "The somatic mutation theory critique and nuclear-transfer evidence",
   "timestamp": "1:06:16",
   "summary": "Seyfried attacks the mainstream view that cancer is a genetic disease, citing nuclear-transfer experiments showing the cytoplasm/mitochondria — not the nucleus — drive dysregulated growth, and 'wild type' cancers with driver mutations in normal cells."
  },
  {
   "name": "The death toll, accountability, and the MORE Alliance",
   "timestamp": "1:09:10",
   "summary": "Seyfried cites 2026 American Cancer Society projections (~626,000 US deaths), criticizes 'breakthrough' marketing and lack of accountability, and describes founding the MORE Alliance (Metabolic Oncology Research and Education)."
  },
  {
   "name": "Prevention policy — the 'if you were president/king' framing",
   "timestamp": "1:14:21",
   "summary": "Asked how he would reduce cancer deaths as president, Seyfried prioritizes patient education, ending food deserts, exercise, and stress reduction, while insisting government should never dictate what people eat."
  },
  {
   "name": "Fasting, the 'wall,' and continuous monitoring apps",
   "timestamp": "1:22:48",
   "summary": "Discussion of intermittent and water-only fasting, the ~3-day 'wall,' Valter Longo's fasting-mimicking research, glucose as an addictive drug, and coming AI-powered glucose/ketone monitoring and food-scanning apps."
  },
  {
   "name": "Hyperbaric oxygen, standard-of-care harm, and metastasis",
   "timestamp": "1:27:27",
   "summary": "Seyfried explains hyperbaric oxygen selectively kills cancer cells in ketosis, warns that high-dose standard treatments push the body into the 'red zone,' and describes metastatic cells as glutamine-driven macrophage-tumor hybrids targetable by Press-Pulse therapy."
  },
  {
   "name": "Copernican analogy and the closing message of hope",
   "timestamp": "1:36:29",
   "summary": "Seyfried likens challenging the genetic-cancer paradigm to Copernicus and the martyr Giordano Bruno, then closes with an actionable takeaway (learn the science, work with knowledgeable physicians), foundations that fund his philanthropy-supported work, and the belief the system will eventually change."
  }
 ],
 "entities": [
  {
   "name": "Thomas Seyfried",
   "type": "person",
   "salience": "central",
   "role_in_episode": "Guest — cancer biologist at Boston College who argues cancer is a mitochondrial metabolic disease, presents the Glucose Ketone Index and Press-Pulse metabolic therapy, and criticizes mainstream oncology."
  },
  {
   "name": "Steven Bartlett",
   "type": "person",
   "salience": "central",
   "role_in_episode": "Host who interviews Seyfried, repeatedly plays back the biology to check understanding, supplies researched statistics and studies, and takes a live GKI reading."
  },
  {
   "name": "cancer",
   "type": "concept",
   "salience": "central",
   "role_in_episode": "The episode's subject — reframed by Seyfried as a mitochondrial metabolic disorder of dysregulated cell growth rather than a genetic disease."
  },
  {
   "name": "mitochondria",
   "type": "concept",
   "salience": "central",
   "role_in_episode": "The organelle at the center of Seyfried's entire thesis — the 'powerhouse' whose chronic damage he says causes cancer and all chronic diseases."
  },
  {
   "name": "Glucose Ketone Index",
   "type": "concept",
   "salience": "central",
   "role_in_episode": "Seyfried's biomarker tool (GKI = glucose in mmol/L divided by ketones in mmol/L) presented as the first measure of mitochondrial health and the guide to 'prevention' vs 'risk' zones."
  },
  {
   "name": "ketogenic diet",
   "type": "concept",
   "salience": "central",
   "role_in_episode": "The dietary intervention (nutritional ketosis) at the heart of Seyfried's prevention and management strategy, used to starve tumors and protect healthy cells during chemo."
  },
  {
   "name": "glutamine",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "The amino acid Seyfried names as the second tumor fuel alongside glucose — the most abundant amino acid in the blood and the driver of metastatic and cachexia processes."
  },
  {
   "name": "glucose",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "One of the two primary tumor fuels; also discussed as an addictive drug and the volatile numerator of the GKI."
  },
  {
   "name": "ketones",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "Fat-derived fuel that healthy cells can burn but cancer cells cannot, because their mitochondria are damaged; the denominator of the GKI."
  },
  {
   "name": "oxidative phosphorylation",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "The oxygen-dependent mitochondrial energy pathway whose impairment Seyfried says every carcinogen and cancer mutation ultimately damages."
  },
  {
   "name": "fermentation",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "The ancient, oxygen-independent energy pathway cancer cells fall back on; its waste products (lactic and succinic acid) are said to shield tumors from therapy."
  },
  {
   "name": "Warburg effect",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "Otto Warburg's observation that cancer cells ferment even in full oxygen — the empirical anchor for Seyfried's mitochondrial-damage theory."
  },
  {
   "name": "Otto Warburg",
   "type": "person",
   "salience": "discussed",
   "role_in_episode": "German biochemist whose 1920s-40s work Seyfried builds on, credited with first showing cancer as a mitochondrial metabolic disease and later 'thrown under the bus' by the genetic view."
  },
  {
   "name": "somatic mutation theory",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "The mainstream view that cancer is caused by random DNA mutations, which Seyfried argues is wrong, citing nuclear-transfer experiments and 'wild type' cancers."
  },
  {
   "name": "Press-Pulse therapy",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "Seyfried's therapeutic strategy (built with Dominic D'Agostino and Joe Maroon) to 'press' down tumor glucose and 'pulse' to kill glutamine metabolism, especially in metastatic cells."
  },
  {
   "name": "glioblastoma",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "The deadly brain cancer with no major advance in 100 years, used as Seyfried's showcase for metabolic therapy via long-term survivors Pablo Kelly and Andrew Scarborough."
  },
  {
   "name": "metastasis",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "The spread of tumors, explained by Seyfried as driven by glutamine-dependent macrophage-tumor hybrid cells that Press-Pulse therapy can target."
  },
  {
   "name": "cachexia",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "Cancer wasting syndrome; Seyfried reframes it as the tumor pulling glutamine from muscle, distinguishing pathological cachexia from therapeutic ketogenic weight loss."
  },
  {
   "name": "hyperbaric oxygen therapy",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "An adjunct that, combined with ketosis, selectively kills cancer cells via oxidative stress, per a 2013 study Seyfried published with Dominic D'Agostino."
  },
  {
   "name": "forever chemicals",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "PFAS and microplastics cited as environmental carcinogens that damage mitochondrial oxidative phosphorylation; upgraded by IARC to a group-one carcinogen in late 2023."
  },
  {
   "name": "intermittent fasting",
   "type": "concept",
   "salience": "discussed",
   "role_in_episode": "Discussed as a lever to lower the GKI, with the ~3-day 'wall' and Valter Longo's fasting-mimicking research on making therapies more effective."
  },
  {
   "name": "mebendazole",
   "type": "product",
   "salience": "mentioned",
   "role_in_episode": "A repurposed drug Seyfried says targets both glucose and glutamine, the two tumor fuels."
  },
  {
   "name": "sleep",
   "type": "concept",
   "salience": "mentioned",
   "role_in_episode": "Named as a way to restore mitochondrial energy efficiency and give the organelle a break from chronic stress."
  },
  {
   "name": "Boston College",
   "type": "organization",
   "salience": "mentioned",
   "role_in_episode": "Where Seyfried's research group continues the metabolic-cancer work originated by Otto Warburg."
  },
  {
   "name": "American Cancer Society",
   "type": "organization",
   "salience": "mentioned",
   "role_in_episode": "Source of the 2026 US cancer projections (~626,000 deaths, ~2.11 million new cases) cited repeatedly in the episode."
  },
  {
   "name": "National Cancer Institute",
   "type": "organization",
   "salience": "mentioned",
   "role_in_episode": "Criticized by Seyfried for stating on its website that cancer is a genetic disease."
  },
  {
   "name": "MORE Alliance",
   "type": "organization",
   "salience": "mentioned",
   "role_in_episode": "The new society (Metabolic Oncology Research and Education) Seyfried is developing to organize the metabolic approach to cancer."
  },
  {
   "name": "Pablo Kelly",
   "type": "person",
   "salience": "mentioned",
   "role_in_episode": "Devon, England man with inoperable glioblastoma who refused chemo/radiation, used metabolic therapy, and lived ~10 years — Seyfried's flagship case."
  },
  {
   "name": "Valter Longo",
   "type": "person",
   "salience": "mentioned",
   "role_in_episode": "Longevity researcher whose fasting-mimicking diet research (lowering IGF-1, boosting therapy efficacy) Steven cites in support of the metabolic approach."
  },
  {
   "name": "GLP-1",
   "type": "concept",
   "salience": "mentioned",
   "role_in_episode": "Weight-loss drugs (Ozempic) Seyfried notes lower blood sugar but whose effect on ketones and the GKI is untested, so he withholds judgment."
  }
 ],
 "claims": [
  {
   "holder": "Thomas Seyfried",
   "claim": "Cancer is fundamentally a mitochondrial metabolic disorder, not a genetic disease.",
   "stance": "assertion",
   "conviction": 0.95,
   "subjects": [
    "cancer",
    "mitochondria"
   ],
   "timestamp": "1:36:31",
   "quote": "It is a mitochondrial metabolic disorder."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "The origin of cancer resides in the mitochondrion, not the nucleus.",
   "stance": "assertion",
   "conviction": 0.9,
   "subjects": [
    "cancer",
    "mitochondria"
   ],
   "timestamp": "4:07",
   "quote": "It means that the origin of the disease resides in the organelle called the mitochondrion."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "All chronic diseases and cancer are the result of damage to the mitochondria.",
   "stance": "assertion",
   "conviction": 0.9,
   "subjects": [
    "cancer",
    "mitochondria"
   ],
   "timestamp": "1:29:37",
   "quote": "All chronic diseases and cancer are the result of damage to this organelle."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "The mainstream cancer field refuses to accept the mitochondrial-metabolic origin of cancer, which is a tragedy.",
   "stance": "opinion",
   "conviction": 0.85,
   "subjects": [
    "cancer"
   ],
   "timestamp": "1:25",
   "quote": "the field of cancer has yet to accept it. That is a tragedy."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Cancer cells continue to ferment even in 100% oxygen (the Warburg effect), which indicates their mitochondria are damaged.",
   "stance": "assertion",
   "conviction": 0.85,
   "subjects": [
    "Warburg effect",
    "cancer",
    "fermentation"
   ],
   "timestamp": "18:05",
   "quote": "These cancer cells continue to ferment even in 100% of oxygen."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Cancer cells cannot grow without glucose and glutamine and cannot switch to burning fatty acids or ketone bodies.",
   "stance": "assertion",
   "conviction": 0.85,
   "subjects": [
    "cancer",
    "glucose",
    "glutamine"
   ],
   "timestamp": "55:48",
   "quote": "the cancer can't grow without glucose and glutamine and can't switch to fatty acids or ketone bodies."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Cancer cells cannot use ketones for energy because the mitochondria they would need are structurally and functionally corrupted.",
   "stance": "assertion",
   "conviction": 0.85,
   "subjects": [
    "cancer",
    "ketones",
    "mitochondria"
   ],
   "timestamp": "54:21",
   "quote": "The tumor cells can't tap into the value of a ketone because the organelle needed in the tumor cell to do that is corrupted structurally and functionally."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "The Glucose Ketone Index is the first biomarker tool that lets people know the level of health of their mitochondria.",
   "stance": "assertion",
   "conviction": 0.8,
   "subjects": [
    "Glucose Ketone Index",
    "mitochondria"
   ],
   "timestamp": "38:38",
   "quote": "the first biomarker tool that can allow people to know the level of health in their mitochondria."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Staying in the low-GKI 'prevention' zones makes it very hard to get cancer or chronic disease because it keeps the mitochondria healthy.",
   "stance": "assertion",
   "conviction": 0.8,
   "subjects": [
    "Glucose Ketone Index",
    "ketogenic diet",
    "cancer"
   ],
   "timestamp": "52:37",
   "quote": "It's very hard to get cancer or chronic diseases when you're in these zones because you're keeping this organelle quite healthy."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Nutritional ketosis facilitates the delivery of chemo drugs to the tumor, so much lower doses produce a bigger effect.",
   "stance": "assertion",
   "conviction": 0.8,
   "subjects": [
    "ketogenic diet",
    "cancer"
   ],
   "timestamp": "59:41",
   "quote": "the ketogenic state of nutritional ketosis facilitates the delivery of drugs to the tumor cell. It actually makes, you can use lower doses of drugs and you get bigger effect."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "The fermentation waste products (lactic acid and succinic acid) are what protect tumor cells from chemo and radiation.",
   "stance": "assertion",
   "conviction": 0.75,
   "subjects": [
    "cancer",
    "fermentation"
   ],
   "timestamp": "1:03:09",
   "quote": "what protects the tumor cell from chemo and radiation is the waste products of fermentation."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "He is not against chemotherapy — it is beneficial when used in the right context (in ketosis, at low doses).",
   "stance": "opinion",
   "conviction": 0.8,
   "subjects": [
    "cancer",
    "ketogenic diet"
   ],
   "timestamp": "1:28:53",
   "quote": "I'm positive about it, but it has to be used in the right context."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "High-dose standard-of-care treatments themselves stress the body into the metabolic 'red zone' and make tumor cells stronger and more resistant.",
   "stance": "opinion",
   "conviction": 0.7,
   "subjects": [
    "cancer"
   ],
   "timestamp": "1:27:59",
   "quote": "You go into the red zone from the very treatments that you're giving to the patient, which is making strength in the tumor cells."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Nuclear-transfer experiments show it is the cytoplasm (mitochondria), not the nucleus, that drives dysregulated cell growth, refuting the somatic mutation theory.",
   "stance": "assertion",
   "conviction": 0.85,
   "subjects": [
    "somatic mutation theory",
    "mitochondria",
    "cancer"
   ],
   "timestamp": "1:08:40",
   "quote": "Then you take the nucleus of the normal cell and put it into the cytoplasm of a tumor cell and you get dysregulated cell growth."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Inherited cancer mutations (e.g. BRCA1) are not 100% penetrant, making them secondary risk factors rather than the primary cause.",
   "stance": "assertion",
   "conviction": 0.75,
   "subjects": [
    "cancer",
    "somatic mutation theory"
   ],
   "timestamp": "33:36",
   "quote": "But none of these mutations are 100% penetrant, meaning that they're secondary risk factors."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Modern lifestyle — highly processed carbohydrates, inactivity, emotional stress, and poor sleep — chronically damages the mitochondria and drives the chronic-disease and cancer epidemics.",
   "stance": "assertion",
   "conviction": 0.8,
   "subjects": [
    "cancer",
    "mitochondria"
   ],
   "timestamp": "30:30",
   "quote": "We are now in a new environment where we have massive amounts of highly processed carbohydrates, inactivity, emotional stress. We have poor sleep habits."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Sleep restores the energy efficiency of the mitochondria.",
   "stance": "assertion",
   "conviction": 0.7,
   "subjects": [
    "sleep",
    "mitochondria"
   ],
   "timestamp": "42:51",
   "quote": "Sleep is a way we can restore the energy efficiency of the mitochondria."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Cachexia (pathological wasting) is the tumor mobilizing glutamine out of muscle, so ketogenic weight loss is therapeutic rather than the pathological weight loss oncologists fear.",
   "stance": "assertion",
   "conviction": 0.75,
   "subjects": [
    "cachexia",
    "cancer",
    "glutamine",
    "ketogenic diet"
   ],
   "timestamp": "1:04:46",
   "quote": "So when you put a patient in nutritional ketosis, the weight loss is therapeutic weight loss. Cackexia is pathological weight loss."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Metastatic tumor cells are glutamine-driven macrophage-tumor hybrids that metabolic therapy, done correctly, can target and 'nail'.",
   "stance": "assertion",
   "conviction": 0.7,
   "subjects": [
    "metastasis",
    "glutamine",
    "Press-Pulse therapy"
   ],
   "timestamp": "1:31:30",
   "quote": "metabolic therapy, done the right way, can nail those metastatic cancer cells."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Combining nutritional ketosis with hyperbaric oxygen selectively kills cancer cells, which lack efficient oxidative phosphorylation.",
   "stance": "assertion",
   "conviction": 0.7,
   "subjects": [
    "hyperbaric oxygen therapy",
    "cancer",
    "ketogenic diet"
   ],
   "timestamp": "1:27:59",
   "quote": "you can put a patient in nutritional ketosis and then put them in hyperbaric oxygen, and the cancer cells are selectively killed."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "The cancer establishment celebrates six extra months of survival as a breakthrough, whereas metabolic therapy is about five to six extra years.",
   "stance": "opinion",
   "conviction": 0.75,
   "subjects": [
    "cancer",
    "ketogenic diet"
   ],
   "timestamp": "1:03:09",
   "quote": "they think living in extra six months is a major breakthrough. We're talking about living in extra five and six years."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "You cannot make someone healthy by irradiating and poisoning them; you must understand the biology and biochemistry of the disease.",
   "stance": "opinion",
   "conviction": 0.85,
   "subjects": [
    "cancer"
   ],
   "timestamp": "1:09:12",
   "quote": "You don't make someone healthy by irradiating and poisoning them."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "The profitability of the cancer industries is based on patients' sickness rather than their recovery.",
   "stance": "opinion",
   "conviction": 0.75,
   "subjects": [
    "cancer"
   ],
   "timestamp": "1:34:02",
   "quote": "the profitability of the industries are based on your sickness."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Reducing cancer should be driven by patient education, not by government dictating what people may eat.",
   "stance": "opinion",
   "conviction": 0.8,
   "subjects": [
    "cancer",
    "Glucose Ketone Index"
   ],
   "timestamp": "1:15:44",
   "quote": "It should not be any government or government official telling anyone what they should or should not eat"
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "The most important first lever for a president trying to reduce cancer deaths would be education.",
   "stance": "opinion",
   "conviction": 0.75,
   "subjects": [
    "cancer"
   ],
   "timestamp": "1:15:40",
   "quote": "It's going to be education."
  },
  {
   "holder": "Thomas Seyfried",
   "claim": "Glucose acts like an addictive drug on the brain, comparable to cocaine, which is why cutting carbs causes withdrawal-like symptoms.",
   "stance": "opinion",
   "conviction": 0.6,
   "subjects": [
    "glucose"
   ],
   "timestamp": "1:22:58",
   "quote": "the power of glucose is an addictive drug on the brain. It's unbelievable. It's like cocaine."
  }
 ],
 "predictions": [
  {
   "holder": "Thomas Seyfried",
   "prediction": "His embargoed paper will be published as a lead article in Frontiers in Science and prove very important as a strategy to manage cancer.",
   "timeframe": "unspecified (upcoming)",
   "subjects": [
    "cancer"
   ],
   "timestamp": "1:04",
   "quote": "It's a paper that's under embargo because the world thinks it's going to be very important. And it's going to be a lead article for the frontiers in science."
  },
  {
   "holder": "Thomas Seyfried",
   "prediction": "As more successful case reports are published, the cancer system will change.",
   "timeframe": "unspecified",
   "subjects": [
    "cancer"
   ],
   "timestamp": "1:44:51",
   "quote": "we keep publishing more and more case reports of successful cases, and the system will change."
  },
  {
   "holder": "Thomas Seyfried",
   "prediction": "AI-powered continuous glucose-ketone monitors and food-scanning apps that place a food on the GKI chart are coming.",
   "timeframe": "near-term",
   "subjects": [
    "Glucose Ketone Index"
   ],
   "timestamp": "1:18:38",
   "quote": "it's purely patient empowerment"
  },
  {
   "holder": "Thomas Seyfried",
   "prediction": "He would put his metabolic therapy against any pharmaceutical trial and keep patients alive far longer.",
   "timeframe": "unspecified",
   "subjects": [
    "cancer",
    "ketogenic diet"
   ],
   "timestamp": "1:13:19",
   "quote": "I will put up our metabolic therapy against any trial from any of these pharmaceutical companies. We can keep these people alive a hell of a lot longer"
  }
 ],
 "facts": [
  {
   "statement": "Seyfried's work builds on Otto Warburg, who from the 1920s-40s showed cancer was a mitochondrial metabolic disease.",
   "subjects": [
    "Otto Warburg",
    "cancer"
   ],
   "value": "1920s-40s",
   "timestamp": "3:47",
   "quote": "my work is based on what Otto Werberg, the famous German scientist said from the 1920s, 30s and 40s.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Roughly 1,700 people a day die from cancer in the United States — about 70 an hour.",
   "subjects": [
    "cancer"
   ],
   "value": "~1,700/day; ~70/hour",
   "timestamp": "1:43",
   "quote": "There's 1,700 people a day in this country dying from cancer. That's 70 an hour.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "The American Cancer Society projects roughly 626,000 US cancer deaths in 2026.",
   "subjects": [
    "cancer",
    "American Cancer Society"
   ],
   "value": "626,000 deaths (2026)",
   "timestamp": "1:09:12",
   "quote": "American Cancer Society says this year in 2026, we will have 626,000 souls leave the planet from cancer",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "The ACS projects over 2.11 million new US cancer diagnoses in 2026, roughly 5,800 new cases per day.",
   "subjects": [
    "cancer",
    "American Cancer Society"
   ],
   "value": ">2.11M new cases; ~5,800/day",
   "timestamp": "1:10:43",
   "quote": "the ACS projects over 2.11 million new cancer diagnoses in 2026 This translates roughly to 5,800 new cases every single day.",
   "source": "Steven Bartlett"
  },
  {
   "statement": "Lung cancer remains the leading cause of cancer death, projected to cause more fatalities than colorectal and pancreatic cancers combined.",
   "subjects": [
    "cancer"
   ],
   "timestamp": "1:11:11",
   "quote": "Lung cancer remains the leading cause of cancer death, projected to cause more fatalities than colorectal and pancreatic cancers combined.",
   "source": "Steven Bartlett"
  },
  {
   "statement": "Mitochondria produce about 34-36 ATP with oxygen, versus only about two moles of energy from fermentation.",
   "subjects": [
    "oxidative phosphorylation",
    "fermentation"
   ],
   "value": "34-36 ATP vs ~2",
   "timestamp": "25:02",
   "quote": "Like 34 to 36 ATP's.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Glutamine is the most abundant amino acid in the bloodstream.",
   "subjects": [
    "glutamine"
   ],
   "timestamp": "25:43",
   "quote": "That's the most abundant amino acid in our bloodstream.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Cancer is the number one killer of the domestic dog, while wolves in the wild rarely have cancer.",
   "subjects": [
    "cancer"
   ],
   "timestamp": "1:58",
   "quote": "cancer is the number one killer of the domestic dog. But wolves in the wild rarely have cancer.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Low-income countries like Niger, Gambia, and Nepal rank lowest for cancer incidence, while high-income countries like Australia, New Zealand, and the US have the highest rates.",
   "subjects": [
    "cancer"
   ],
   "timestamp": "30:05",
   "quote": "countries like Niger, Gambia, Nepal, consistently rank at the very bottom for cancer incidence. Conversely, high-income countries like Australia, New Zealand and the United States have the highest rates of cancer.",
   "source": "Steven Bartlett"
  },
  {
   "statement": "The GKI originated with cancer patient Trudy DuPont, who used metabolic therapy for a brainstem tumor and stayed alive over 10 years.",
   "subjects": [
    "Glucose Ketone Index",
    "Trudy DuPont"
   ],
   "value": ">10 years",
   "timestamp": "46:38",
   "quote": "She stayed alive much longer, over 10 years with this.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Steven Bartlett's live GKI reading was 12.5 (glucose 90 mg/dL, ketones 0.4 mmol/L), placing him in the prevention zone.",
   "subjects": [
    "Glucose Ketone Index",
    "Steven Bartlett"
   ],
   "value": "GKI 12.5",
   "timestamp": "51:54",
   "quote": "12.5. You're down here in the prevention zone.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Ketoacidosis occurs at ketone levels of about 15 to 20 millimolar, far above the ~0.4 mmol/L of nutritional ketosis.",
   "subjects": [
    "ketones"
   ],
   "value": "15-20 mmol/L",
   "timestamp": "54:21",
   "quote": "Ketoacidosis is like when you have ketone levels of 15 to 20 millimolar.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Pablo Kelly of Devon, England, diagnosed with inoperable glioblastoma, refused radiation and chemo, used only metabolic therapy, and lived for 10 years.",
   "subjects": [
    "glioblastoma",
    "Pablo Kelly"
   ],
   "value": "10 years",
   "timestamp": "58:44",
   "quote": "people like Pablo Kelly from Devon, England, he had the glioblastoma. He didn't take any radiation or chemo. He just did metabolic therapy. He lived for 10 years.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Andrew Scarborough of England has managed stage 3 glioma with metabolic therapy for about 15 years.",
   "subjects": [
    "glioblastoma"
   ],
   "value": "~15 years",
   "timestamp": "1:26:25",
   "quote": "Andrew Scarborough from England, who's been doing this for stage 3 glioma, he's like 15 years out.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "There has been no major advance in managing glioblastoma in 100 years.",
   "subjects": [
    "glioblastoma"
   ],
   "value": "100 years",
   "timestamp": "1:13:19",
   "quote": "There has been no major advance in managing glioblastoma in 100 years.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Glioblastoma killed Ted Kennedy, John McCain, and Beau Biden (President Biden's son).",
   "subjects": [
    "glioblastoma"
   ],
   "timestamp": "1:13:26",
   "quote": "That killed Teddy Kennedy from Massachusetts, Senator Kennedy, John McCain, President Biden's son, Bo Biden",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Seyfried is developing a new society, the MORE Alliance (Metabolic Oncology Research and Education).",
   "subjects": [
    "MORE Alliance"
   ],
   "timestamp": "1:12:33",
   "quote": "the new society called MORE, the MORE Alliance, Metabolic Oncology Research and Education.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Seyfried identifies mebendazole, a repurposed drug, as targeting both glucose and glutamine, the two tumor fuels.",
   "subjects": [
    "mebendazole",
    "glucose",
    "glutamine"
   ],
   "timestamp": "55:48",
   "quote": "It targets glucose and glutamine.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "The Press-Pulse therapeutic strategy was built by Seyfried with Dominic D'Agostino and Joe Maroon.",
   "subjects": [
    "Press-Pulse therapy"
   ],
   "timestamp": "1:31:30",
   "quote": "my colleagues and I, Dom DiAgostino, Joe Maroon, we built the Press Pulse Therapeutic Strategy.",
   "source": "Thomas Seyfried"
  },
  {
   "statement": "Valter Longo's research found fasting-mimicking diets lower IGF-1, trigger autophagy, and make standard cancer therapies up to three times more effective.",
   "subjects": [
    "Valter Longo",
    "intermittent fasting"
   ],
   "value": "up to 3x more effective",
   "timestamp": "1:24:44",
   "quote": "fasting-mimicking diets drastically lower IGF-1, which triggers cellular autophagy and actually make standard cancer therapies up to three times more effective by removing the metabolic shield of cancer cells.",
   "source": "Steven Bartlett"
  },
  {
   "statement": "A 2013 study found that combining a ketogenic diet with hyperbaric oxygen therapy synergistically decreased tumor growth and increased survival in metastatic cancer mouse models.",
   "subjects": [
    "hyperbaric oxygen therapy",
    "ketogenic diet"
   ],
   "value": "2013 study",
   "timestamp": "1:27:29",
   "quote": "There was a study in 2013 that demonstrated that while a ketogenic diet alone significantly slowed tumor growth and systemic metastatic cancer mouse models, combining the diet with hyperbaric oxygen therapy, elicited a profound synergetic decrease in tumor growth and drastically increase survival times.",
   "source": "Steven Bartlett"
  },
  {
   "statement": "In late 2023 the International Agency for Research on Cancer upgraded forever chemicals (used in non-stick pans and food packaging) to a group-one carcinogen in humans.",
   "subjects": [
    "forever chemicals"
   ],
   "value": "IARC group 1 (late 2023)",
   "timestamp": "1:29:10",
   "quote": "In late 2023, the International Agency of Research on Cancer officially upgraded these forever chemicals, which are used in non-stick pans and food packaging, to a grade one carcinogen in humans",
   "source": "Steven Bartlett"
  }
 ],
 "notable_quotes": [
  {
   "speaker": "Thomas Seyfried",
   "timestamp": "1:04",
   "quote": "We have given hope to the hopeless.",
   "why": "Seyfried's framing of his metabolic-therapy mission, stated in the opening minute while introducing the embargoed paper."
  },
  {
   "speaker": "Thomas Seyfried",
   "timestamp": "1:03:09",
   "quote": "The problem in the field of cancer today is they're not using the tools in the correct way.",
   "why": "Encapsulates his central critique — that existing chemo, radiation, and immunotherapy could work far better if deployed with metabolic therapy."
  },
  {
   "speaker": "Thomas Seyfried",
   "timestamp": "1:09:12",
   "quote": "You don't make someone healthy by irradiating and poisoning them.",
   "why": "His blunt indictment of the high-toxicity standard of care, delivered amid the death-toll statistics."
  },
  {
   "speaker": "Thomas Seyfried",
   "timestamp": "1:34:02",
   "quote": "the profitability of the industries are based on your sickness.",
   "why": "The episode's most pointed accusation about why the metabolic approach is ignored — a systemic-incentives claim aimed at patients."
  },
  {
   "speaker": "Thomas Seyfried",
   "timestamp": "1:03:09",
   "quote": "they think living in extra six months is a major breakthrough. We're talking about living in extra five and six years.",
   "why": "The survival contrast that quantifies his claim for what metabolic therapy adds over standard care."
  }
 ],
 "extracted_by": "agent",
 "prompt_version": "episode-extract@3",
 "_file": "the-diary-of-a-ceo-2026-07-16-leading-cancer-researcher-they-re-ignoring-my-research-cance.json"
}